Latest Pharma News... Sep 16
Fifth disease that Dupixent has demonstrated positive pivotal results.... Jul 29
The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
Roche today announced a partnership with Moderna Inc. to utilize the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine ... Dec 09
Vyriad, Inc. announced today the addition of new clinical sites in its ongoing clinical study evaluating an intravesical oncolytic measles virus therapy in bladder cancer ... Dec 02
Atopic dermatitis is a chronic inflammatory disease of the skin that can be debilitating, and severe disease can significantly impact many aspects of life for ... Nov 30
The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ... Nov 23
In the USA, approximately 7 per cent of adults have been diagnosed with severe hypercholesterolemia, which is defined as having untreated LDL cholesterol at levels ... Nov 18
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD.... Nov 06
Libtayo is indicated for advanced non-smal cell cancer with PD-L1 Expression of ≥50%... Oct 31
First FDA approved antibody treatment for Ebola... Oct 19
The antiviral medication was one of the drugs used to treat U.S. President Donald Trump’s coronavirus infection, and has been shown in previous ... Oct 16
ELI Lilly, J & J and AstraZeneca halts covid drug trials... Oct 15
A pivotal Phase 3 trial of Dupixent met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-... Oct 13
Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients... Oct 02
Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo® (cemiplimab) in first-line locally advanced or metastatic non-small cell lung ... Sep 21
COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK... Sep 18
The coronavirus, SARS-CoV-2, is the latest in a procession of new infectious diseases that have surprised the world in recent years... Sep 15
As part of the government-backed Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trials, monoclonal antibodies... Sep 15
The pivotal trial is event-based and there are many variables that will ultimately impact read-out timing... Sep 14
The rheumatoid arthritis drug Kevzara from Sanofi fails Covid clinical trials... Sep 02
The London-listed firm is already among the leading players in the global race to develop a successful vaccine against COVID-19.... Aug 25
The FDA granted evinacumab breakthrough therapy designation in 2017 for the treatment of hypercholesterolemia in patients with HoFH... Aug 13
Coronavirus: More than 3.5 million people have tested positive with the coronavirus and 138,000 died in the US. ... Jul 17
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)